Sophoricoside ameliorates cardiac hypertrophy by activating AMPK/mTORC1-mediated autophagy

Aim: The study aims to evaluate protective effects of sophoricoside (Sop) on cardiac hypertrophy. Meanwhile, the potential and significance of Sop should be broadened and it should be considered as an attractive drug for the treatment of pathological cardiac hypertrophy and heart failure. Methods: U...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biosci Rep
Main Authors: Gao, Maomao, Hu, Fengjiao, Hu, Manli, Hu, Yufeng, Shi, Hongjie, Zhao, Guo-Jun, Jian, Chongshu, Ji, Yan-Xiao, Zhang, Xiao-Jing, She, Zhi-Gang, Li, Hongliang, Zhu, Lihua
Formato: Artigo
Idioma:Inglês
Publicado em: Portland Press Ltd. 2020
Assuntos:
Cardiovascular System & Vascular Biology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7677750/
https://ncbi.nlm.nih.gov/pubmed/32964914
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1042/BSR20200661
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados